{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T04:22:07Z","timestamp":1778991727313,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.joms.2017.07.172","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T16:46:00Z","timestamp":1501778760000},"page":"474-482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of Mandibular Bone After Dental Extraction in Rats Treated With Antiresorptive Drugs"],"prefix":"10.1016","volume":"76","author":[{"given":"Victor Lousan do Nascimento","family":"Poubel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diogo Lenzi","family":"Capella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adair Roberto Soares","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcio","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Let\u00edcia","family":"Ruhland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena Riet Correa","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2017.07.172_bib1","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 Update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2017.07.172_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: Different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.joms.2017.07.172_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1359\/jbmr.081112","article-title":"Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL","volume":"24","author":"Kostenuik","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2017.07.172_bib4","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/jbmr.5650111016","article-title":"Dissociation of binding and antiresorptive properties of hydroxybisphosphonates by substitution of the hydroxyl with an amino group","volume":"11","author":"Van Beek","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2017.07.172_bib5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1684\/bdc.2011.1398","volume":"98","author":"Cl\u00e9zardin","year":"2011","journal-title":"Bull Cancer"},{"key":"10.1016\/j.joms.2017.07.172_bib6","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1124\/mol.105.020776","article-title":"Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis","volume":"69","author":"Thompson","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.joms.2017.07.172_bib7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrclinonc.2014.152","article-title":"Breast cancer: Zoledronic acid\u2014More than just a bone drug","volume":"11","author":"Mathew","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.joms.2017.07.172_bib8","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","article-title":"Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL","volume":"273","author":"Emery","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.joms.2017.07.172_bib9","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00198-007-0363-7","article-title":"The RANKL inhibitor OPG-Fc increases cortical and trabecular bone mass in young gonad-intact cynomolgus monkeys","volume":"18","author":"Ominsky","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.joms.2017.07.172_bib10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2017.07.172_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2017.07.172_bib12","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.archoralbio.2015.05.015","article-title":"Effect of different doses of zoledronic acid in establishing of bisphosphonate-related osteonecrosis","volume":"60","author":"Silva","year":"2015","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.joms.2017.07.172_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/iep.12007","article-title":"Experimental development of bisphosphonate-related osteonecrosis of the jaws in rodents","volume":"94","author":"Conte Neto","year":"2013","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.joms.2017.07.172_bib14","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jcms.2013.11.005","article-title":"Zoledronic acid-related osteonecrosis of the jaws. Experimental model with dental extractions in rats","volume":"42","author":"Barba-Recreo","year":"2014","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2017.07.172_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hed.21422","article-title":"Association between bisphosphonates and jaw osteonecrosis: A study in Wistar rats","volume":"33","author":"Maahs","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.joms.2017.07.172_bib16","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.joms.2014.07.004","article-title":"Bisphosphonate uptake in areas of tooth extraction or periapical disease","volume":"72","author":"Cheong","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2017.07.172_bib17","first-page":"645","article-title":"Pathophysiology of osteonecrosis of the jaw in patients treated with bisphosphonate","volume":"37","author":"Badel","year":"2013","journal-title":"Coll Antropol"},{"key":"10.1016\/j.joms.2017.07.172_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/0976-500X.72351","article-title":"Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research","volume":"1","author":"Kilkenny","year":"2010","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1016\/j.joms.2017.07.172_bib19","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1016\/j.ajpath.2014.07.010","article-title":"Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-\u03baB ligand antibody in mice","volume":"184","author":"Williams","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.joms.2017.07.172_bib20","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1600-0714.2012.01140.x","article-title":"Comparison of effects of clodronate and zoledronic acid on the repair of maxilla surgical wounds\u2014Histomorphometric, receptor activator of nuclear factor-kB ligand, osteoprotegerin, von Willebrand factor, and caspase-3 evaluation","volume":"41","author":"Vasconcelos","year":"2012","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.joms.2017.07.172_bib21","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00784-014-1347-6","article-title":"Periosteal microcirculatory reactions in a zoledronate-induced osteonecrosis model of the jaw in rats","volume":"19","author":"Janovszky","year":"2015","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.joms.2017.07.172_bib22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.bone.2015.08.012","article-title":"Animal model for medication-related osteonecrosis of the jaw with precedent metabolic bone disease","volume":"81","author":"Kim","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.joms.2017.07.172_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00774-009-0128-9","article-title":"Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice","volume":"28","author":"Kobayashi","year":"2010","journal-title":"J Bone Min Metab"},{"key":"10.1016\/j.joms.2017.07.172_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/11203300-000000000-00000","article-title":"Denosumab: A review of its use in the treatment of postmenopausal osteoporosis","volume":"28","author":"Moen","year":"2011","journal-title":"Drugs Aging"},{"key":"10.1016\/j.joms.2017.07.172_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1747-4477.2009.00213.x","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw\u20142009 Update","volume":"35","author":"Ruggiero","year":"2009","journal-title":"Aust Endod J"},{"key":"10.1016\/j.joms.2017.07.172_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/089875641102800413","article-title":"Bisphosphonate related osteonecrosis of the jaws: A review","volume":"28","author":"Stepaniuk","year":"2011","journal-title":"J Vet Dent"},{"key":"10.1016\/j.joms.2017.07.172_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0269216316639793","article-title":"Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: A systematic review within the European Association for Palliative Care guidelines project","volume":"31","author":"Porta-Sales","year":"2017","journal-title":"Palliat Med"},{"key":"10.1016\/j.joms.2017.07.172_bib28","first-page":"13","article-title":"Significant pain relief with loading dose zoledronic acid in bone metastases is only seen in patients with elevated initial serum C telopeptide (CTX)","volume":"2","author":"Dekoninck","year":"2011","journal-title":"Pragmat Obs Res"},{"key":"10.1016\/j.joms.2017.07.172_bib29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: Similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.joms.2017.07.172_bib30","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1601-0825.2010.01677.x","article-title":"Effects of alendronate on bone healing after tooth extraction in rats","volume":"16","author":"Aguirre","year":"2010","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2017.07.172_bib31","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jcms.2015.05.021","article-title":"Correlation of changes in the mandible and retina\/choroid vasculature of a rat model of BRONJ","volume":"43","author":"Borke","year":"2015","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2017.07.172_bib32","first-page":"e99","article-title":"Experimental osteonecrosis: Development of a model in rodents administered alendronate","volume":"30","author":"Conte","year":"2016","journal-title":"Braz Oral Res"},{"key":"10.1016\/j.joms.2017.07.172_bib33","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/jcpe.12455","article-title":"Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: A systematic review and meta-analysis","volume":"42","author":"Gaudin","year":"2015","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.joms.2017.07.172_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-0-387-72009-8_18","article-title":"RANKL inhibition: From mice to men (and women)","volume":"602","author":"Stolina","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.joms.2017.07.172_bib35","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.4049\/jimmunol.179.11.7497","article-title":"Continuous RANKL inhibition in osteoprotegerin transgenic mice and rats suppresses bone resorption without impairing lymphorganogenesis or functional immune responses","volume":"179","author":"Stolina","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.joms.2017.07.172_bib36","doi-asserted-by":"crossref","first-page":"28164","DOI":"10.1074\/jbc.M110.101964","article-title":"Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL","volume":"285","author":"Pierroz","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.joms.2017.07.172_bib37","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1006\/bbrc.2000.3379","article-title":"Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: Modulation of the expression by osteotropic factors and\u00a0cytokines","volume":"275","author":"Nakashima","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.joms.2017.07.172_bib38","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/art.10834","article-title":"Serum osteoprotegerin and its ligand in Paget's disease of bone: Relationship to disease activity and effect of treatment with bisphosphonates","volume":"48","author":"Alvarez","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joms.2017.07.172_bib39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bone.2006.08.003","article-title":"Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget\u2019s disease of bone","volume":"40","author":"Martini","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.joms.2017.07.172_bib40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cid.12297","article-title":"Biomarkers for bisphosphonate-related osteonecrosis of the jaw","volume":"18","author":"Kim","year":"2016","journal-title":"Clin Implant Dent Relat Res"},{"key":"10.1016\/j.joms.2017.07.172_bib41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/03008207.2013.848202","article-title":"Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone","volume":"54","author":"Lau","year":"2013","journal-title":"Connect Tissue Res"},{"key":"10.1016\/j.joms.2017.07.172_bib42","doi-asserted-by":"crossref","first-page":"e0148401","DOI":"10.1371\/journal.pone.0148401","article-title":"Protein expression profiling of giant cell tumors of bone treated with denosumab","volume":"11","author":"Mukaihara","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.joms.2017.07.172_bib43","doi-asserted-by":"crossref","first-page":"749","DOI":"10.21873\/anticanres.11373","article-title":"Pathogenesis of osteosclerotic change following treatment with an antibody against RANKL for giant cell tumour of the bone","volume":"37","author":"Rosario","year":"2017","journal-title":"Anticancer Res"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239117310145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239117310145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:53:41Z","timestamp":1759510421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239117310145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0278239117310145"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2017.07.172","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Mandibular Bone After Dental Extraction in Rats Treated With Antiresorptive Drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2017.07.172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Association of Oral and Maxillofacial Surgeons","name":"copyright","label":"Copyright"}]}}